Nu-Med Plus (NUMD) Net Cash Flow Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.96% |
| Sep 30, 2025 | -19.62% |
| Dec 31, 2024 | 45.52% |
| Jun 30, 2024 | 21.14% |
| Mar 31, 2024 | 68.46% |
| Dec 31, 2023 | -41.72% |
| Sep 30, 2023 | 30.94% |
| Jun 30, 2023 | -30.45% |
| Mar 31, 2023 | 23.23% |
| Dec 31, 2022 | 15.96% |
| Sep 30, 2022 | -66.36% |
| Jun 30, 2022 | 45.75% |
| Mar 31, 2022 | -15.21% |
| Dec 31, 2021 | -30.76% |
| Sep 30, 2021 | -2.38% |
| Jun 30, 2021 | -5.93% |
| Mar 31, 2021 | -23.46% |
| Dec 31, 2020 | 38.61% |
| Sep 30, 2020 | 34.61% |
| Jun 30, 2020 | -39.99% |
| Mar 31, 2020 | 17.71% |
| Dec 31, 2019 | 1.67% |
| Sep 30, 2019 | -13.73% |
| Jun 30, 2019 | -17.50% |
| Mar 31, 2019 | -92.34% |
| Dec 31, 2018 | -15.00% |
| Sep 30, 2018 | -323.80% |
| Jun 30, 2018 | 23.40% |
| Mar 31, 2018 | -93.79% |
| Dec 31, 2017 | 9.10% |
| Sep 30, 2017 | 60.64% |
| Jun 30, 2017 | -5.17% |
| Mar 31, 2017 | 39.35% |